Literature DB >> 27350543

Multiple gut-liver axis abnormalities in children with obesity with and without hepatic involvement.

S Guercio Nuzio1, M Di Stasi1, L Pierri1, J Troisi1,2, M Poeta1, A Bisogno1, F Belmonte1, M Tripodi1, D Di Salvio1, G Massa1, R Savastano1, P Cavallo3, M Boffardi4, D Ziegenhardt5, I Bergheim5, C Mandato6, P Vajro1,7,8.   

Abstract

BACKGROUND: Gut-liver axis (GLA) dysfunction appears to play a role in obesity and obesity-related hepatic complications.
OBJECTIVES: This study sought to concurrently explore several GLA components in a paediatric obese population with/without liver disease.
METHODS: Thirty-two children (mean age 11.2 years) were enrolled: nine controls with normal weight and 23 patients with obesity (OB+). Of the 23 patients OB(+), 12 had not steatosis (ST-), and 11 had steatosis (ST+) (associated [n = 8] or not [n = 3] with hypertransaminasaemia [ALT +/-]). Subjects were characterized by using auxologic, ultrasonographic and laboratory parameters. A glucose hydrogen breath test was performed to test for small intestinal bacterial overgrowth, a urinary lactulose/mannitol ratio (LMR) was obtained to assess intestinal permeability, and tests for transaminases, blood endogenous ethanol, endotoxin and faecal calprotectin were also conducted.
RESULTS: Eleven out of 23 patients OB(+) (p < 0.05) exhibited pathological (>90th percentile of the control group values) LMR, with values paralleling the grade of liver involvement (normal weight < OB[+] < OB[+]ST[+]ALT[-] < OB[+)]ST[+]ALT[+] [p < 0.05]). LMR significantly correlated with ethanolaemia (r = 0.38, p = 0.05) and endotoxaemia (r = 0.48, p = 0.015) concentrations. Increased permeability was a risk factor for the development of steatosis (p < 0.002). SIBO was present only in patients with obesity. Faecal calprotectin concentrations were within normal limits in all subjects.
CONCLUSIONS: Increased permeability, endogenous ethanol and systemic endotoxin concentrations reflect some GLA dysfunction in obesity and its hepatic complications. Pending further results to establish their potential causative roles, the modulation of the GLA appears to represent a possible target for the prevention and treatment of these conditions.
© 2016 World Obesity Federation.

Entities:  

Keywords:  Endotoxin; NAFLD; ethanol; gut-liver axis

Mesh:

Year:  2016        PMID: 27350543     DOI: 10.1111/ijpo.12164

Source DB:  PubMed          Journal:  Pediatr Obes        ISSN: 2047-6302            Impact factor:   4.000


  17 in total

1.  Intestinal Barrier Dysfunction in Fatty Liver Disease: Roles of Microbiota, Mucosal Immune System, and Bile Acids.

Authors:  Biki Gupta; Ravi Rai; Michael Oertel; Reben Raeman
Journal:  Semin Liver Dis       Date:  2022-06-23       Impact factor: 6.512

2.  Fecal SCFAs and SCFA-producing bacteria in gut microbiome of human NAFLD as a putative link to systemic T-cell activation and advanced disease.

Authors:  Monika Rau; Ateequr Rehman; Marcus Dittrich; Albert K Groen; Heike M Hermanns; Florian Seyfried; Niklas Beyersdorf; Thomas Dandekar; Philip Rosenstiel; Andreas Geier
Journal:  United European Gastroenterol J       Date:  2018-09-30       Impact factor: 4.623

3.  Dahuang Zexie Decoction Protects against High-Fat Diet-Induced NAFLD by Modulating Gut Microbiota-Mediated Toll-Like Receptor 4 Signaling Activation and Loss of Intestinal Barrier.

Authors:  Jing Fang; Xiaoqi Sun; Boyu Xue; Nanyuan Fang; Min Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2017-11-12       Impact factor: 2.629

Review 4.  Gut-Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease.

Authors:  Marco Poeta; Luca Pierri; Pietro Vajro
Journal:  Children (Basel)       Date:  2017-08-02

5.  Urinary Metabolomics in Pediatric Obesity and NAFLD Identifies Metabolic Pathways/Metabolites Related to Dietary Habits and Gut-Liver Axis Perturbations.

Authors:  Jacopo Troisi; Luca Pierri; Annamaria Landolfi; Francesca Marciano; Antonella Bisogno; Federica Belmonte; Carmen Palladino; Salvatore Guercio Nuzio; Pietro Campiglia; Pietro Vajro
Journal:  Nutrients       Date:  2017-05-11       Impact factor: 5.717

6.  Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern.

Authors:  Anika Nier; Annette Brandt; Ina Barbara Conzelmann; Yelda Özel; Ina Bergheim
Journal:  Nutrients       Date:  2018-09-19       Impact factor: 5.717

Review 7.  Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.

Authors:  Maria Grazia Clemente; Claudia Mandato; Marco Poeta; Pietro Vajro
Journal:  World J Gastroenterol       Date:  2016-09-28       Impact factor: 5.742

8.  Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children.

Authors:  Anika Nier; Anna Janina Engstler; Ina Barbara Maier; Ina Bergheim
Journal:  PLoS One       Date:  2017-09-07       Impact factor: 3.240

Review 9.  The Role of Prenatal Melatonin in the Regulation of Childhood Obesity.

Authors:  Dmitry O Ivanov; Inna I Evsyukova; Gianluigi Mazzoccoli; George Anderson; Victoria O Polyakova; Igor M Kvetnoy; Annalucia Carbone; Ruslan A Nasyrov
Journal:  Biology (Basel)       Date:  2020-04-05

Review 10.  The relationship between vitamin C status, the gut-liver axis, and metabolic syndrome.

Authors:  Maret G Traber; Garry R Buettner; Richard S Bruno
Journal:  Redox Biol       Date:  2018-12-26       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.